Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free GLUE Stock Alerts

Monte Rosa Therapeutics (GLUE) Short Interest Ratio & Short Volume

Monte Rosa Therapeutics logo
$19.35 -0.22 (-1.12%)
Closing price 04:00 PM Eastern
Extended Trading
$19.34 -0.01 (-0.05%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Monte Rosa Therapeutics Short Interest Overview

As of April 15, 2026, Monte Rosa Therapeutics (GLUE) had a short interest of 15.84 million shares sold short, representing 21.26% of the public float. This marks a 18.20% increase in short interest since the prior report. The short interest ratio (days to cover) is 16.0, meaning it would take 16.0 days of the average trading volume of 1.44 million shares to cover all short positions.

Current Short Interest
15,837,633 shares
Previous Short Interest
13,398,925 shares
Change Vs. Previous Month
18.20%
Dollar Volume Sold Short
$288.72 million
Short Interest Ratio
16.0 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
84,380,000 shares
Short Percent of Float
21.26%
Today's Trading Volume
556,810 shares
Average Trading Volume
1,436,245 shares
Today's Volume Vs. Average
39%
Short Selling Monte Rosa Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GLUE Short Interest Over Time

GLUE Days to Cover Over Time

GLUE Percentage of Float Shorted Over Time

Monte Rosa Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202615,837,633 shares $288.72 million +18.2%21.3%15.99 $18.23
3/31/202613,398,925 shares $220.41 million +22.2%18.0%8.81 $16.45
3/13/202610,964,393 shares $175.65 million +8.4%14.7%12.64 $16.02
2/27/202610,115,500 shares $179.55 million +8.4%16.6%10.7 $17.75
2/13/20269,330,612 shares $167.20 million +21.8%15.3%9.28 $17.92
1/30/20267,664,016 shares $157.27 million +38.0%12.6%6.73 $20.52
1/15/20265,554,802 shares $133.76 million -34.3%9.1%1.37 $24.08
12/31/20258,454,052 shares $132.56 million +20.8%13.9%5.79 $15.68
12/15/20257,001,428 shares $115.17 million -0.1%11.5%9.46 $16.45
11/28/20257,006,369 shares $113.54 million -5.3%11.5%8.62 $16.21
11/14/20257,396,896 shares $106.22 million -7.4%12.1%6.8 $14.36
10/31/20257,988,754 shares $102.66 million -1.2%13.1%7.64 $12.85
10/15/20258,080,000 shares $89.77 million +3.2%21.7%6.5 $11.11
9/30/20257,830,000 shares $58.02 million -5.0%16.9%7.3 $7.41
9/15/20258,240,000 shares $57.10 million No Change17.8%8.2 $6.93
8/31/20258,240,000 shares $39.55 million -1.0%17.8%20.2 $4.80
8/15/20258,320,000 shares $38.11 million -4.4%18.0%18.9 $4.58
7/31/20258,700,000 shares $43.07 million -2.5%18.8%19.3 $4.95
7/15/20258,920,000 shares $46.65 million +0.7%19.4%20.1 $5.23
6/30/20258,860,000 shares $39.96 million -0.1%19.3%16.4 $4.51
6/15/20258,870,000 shares $43.55 million +9.8%19.3%15 $4.91
5/31/20258,080,000 shares $33.45 million -3.8%17.6%12.2 $4.14
5/15/20258,400,000 shares $32.51 million +6.6%18.3%12.4 $3.87
4/30/20257,880,000 shares $38.69 million +4.7%17.1%11.6 $4.91
4/15/20257,530,000 shares $33.36 million +39.2%16.4%10.4 $4.43
3/31/20255,410,000 shares $25.10 million -23.0%11.8%6.9 $4.64
3/15/20257,030,000 shares $44.08 million -12.6%15.3%8.7 $6.27
2/28/20258,040,000 shares $44.22 million +0.1%17.5%8.2 $5.50
2/15/20258,030,000 shares $54.44 million -0.5%17.5%7.6 $6.78
1/31/20258,070,000 shares $53.75 million -7.9%17.6%7 $6.66
1/15/20258,760,000 shares $54.66 million -4.2%19.1%3.2 $6.24
12/31/20249,140,000 shares $63.43 million +8.8%19.9%3.3 $6.94
12/15/20248,400,000 shares $63.50 million -24.0%18.2%3.2 $7.56
11/30/202411,050,000 shares $114.48 million -0.9%23.9%4.5 $10.36
11/15/202411,150,000 shares $86.30 million +42.2%24.1%5.1 $7.74
10/31/20247,840,000 shares $66.64 million +49.9%17.0%3.8 $8.50
10/15/20245,230,000 shares $26.78 million +19.4%11.7%15 $5.12
9/30/20244,380,000 shares $23.21 million +33.9%9.8%12.2 $5.30
9/15/20243,270,000 shares $19.88 million +6.9%7.5%11.7 $6.08
8/31/20243,060,000 shares $18.88 million +9.7%7.2%12.9 $6.17
8/15/20242,790,000 shares $13.67 million +0.4%6.5%11.9 $4.90
7/31/20242,780,000 shares $12.57 million -2.8%6.5%11.2 $4.52
7/15/20242,860,000 shares $11.98 million +11.7%6.7%12.2 $4.19
6/30/20242,560,000 shares $9.57 million +29.3%6.0%11.8 $3.74
6/15/20241,980,000 shares $7.58 million +3.7%4.6%9.9 $3.83
5/31/20241,910,000 shares $7.87 million -17.3%5.0%10.3 $4.12
5/15/20242,310,000 shares $12.08 million +20.9%6.0%13.8 $5.23
4/30/20241,910,000 shares $10.16 million +2.1%6.0%13.7 $5.32
4/15/20241,870,000 shares $12.29 million +11.3%5.9%14.2 $6.57
3/31/20241,680,000 shares $11.84 million -8.2%5.3%11.2 $7.05
3/15/20241,830,000 shares $11.73 million -0.5%5.8%11.2 $6.41
2/29/20241,840,000 shares $11.65 million -7.1%5.8%9.6 $6.33
2/15/20241,980,000 shares $10.95 million +3.7%6.3%9.6 $5.53
1/31/20241,910,000 shares $10.12 million -2.6%6.1%9.1 $5.30
1/15/20241,960,000 shares $11.76 million -4.9%6.2%8 $6.00
12/31/20232,060,000 shares $11.64 million -12.7%6.5%6.6 $5.65
12/15/20232,360,000 shares $11.80 million -20.5%7.5%7.7 $5.00
11/30/20232,970,000 shares $9.21 million -2.9%9.4%10.7 $3.10
11/15/20233,060,000 shares $11.26 million -8.7%9.7%12.1 $3.68
10/31/20233,350,000 shares $11.39 million -10.2%10.8%12.4 $3.40
10/15/20233,730,000 shares $18.02 million -6.8%12.1%15.6 $4.83
9/30/20234,000,000 shares $19.16 million +4.4%12.9%25.8 $4.79
9/15/20233,830,000 shares $23.02 million +7.9%12.4%25.8 $6.01
8/31/20233,550,000 shares $20.84 million +14.2%11.5%23.3 $5.87
8/15/20233,110,000 shares $20.46 million +11.1%10.0%19 $6.58
7/31/20232,800,000 shares $19.80 million +6.5%7.0%19.3 $7.07
7/15/20232,630,000 shares $18.33 million +1.9%6.6%14.1 $6.97
6/30/20232,580,000 shares $17.67 million +5.7%6.5%12.3 $6.85
6/15/20232,440,000 shares $18.03 million +6.6%6.1%11.9 $7.39
5/31/20232,290,000 shares $16.90 million No Change5.8%12 $7.38
5/15/20232,290,000 shares $13.40 million +2.2%5.8%13.5 $5.85
4/30/20232,240,000 shares $10.17 million -10.0%5.6%13.5 $4.54
4/15/20232,490,000 shares $17.06 million +2.9%6.3%16.5 $6.85
3/31/20232,420,000 shares $18.85 million +9.0%6.1%17.2 $7.79
3/15/20232,220,000 shares $14.50 million -3.1%5.6%15.9 $6.53
2/28/20232,290,000 shares $13.92 million -8.0%5.9%15.8 $6.08
2/15/20232,490,000 shares $16.98 million -33.2%6.4%17.1 $6.82
1/31/20233,730,000 shares $27.60 million -0.8%9.6%22.6 $7.40
1/15/20233,760,000 shares $29.37 million -13.4%9.7%25.9 $7.81
12/30/20224,340,000 shares $33.03 million +1.4%11.2%27.7 $7.61
12/15/20224,280,000 shares $40.57 million -1.8%11.1%24 $9.48
11/30/20224,360,000 shares $36.97 million -6.6%14.6%20.1 $8.48
11/15/20224,670,000 shares $43.99 million -4.3%15.7%20.7 $9.42
10/31/20224,880,000 shares $44.90 million +1.2%16.4%21.3 $9.20
10/15/20224,820,000 shares $37.45 million -6.2%16.2%21.3 $7.77
9/30/20225,140,000 shares $41.99 million +4.5%17.3%23 $8.17
9/15/20224,920,000 shares $39.26 million -3.3%16.6%24.2 $7.98
8/31/20225,090,000 shares $40.31 million +6.5%17.2%26.3 $7.92
8/15/20224,780,000 shares $47.51 million +3.5%16.1%23.4 $9.94
7/31/20224,620,000 shares $41.90 million No Change15.6%23.8 $9.07
7/15/20224,620,000 shares $47.36 million -0.9%15.6%23.8 $10.25
6/30/20224,660,000 shares $45.06 million -5.5%15.7%23.2 $9.67
6/15/20224,930,000 shares $37.76 million -13.7%16.6%23.6 $7.66
5/31/20225,710,000 shares $44.20 million +1.1%19.3%22.2 $7.74
5/15/20225,650,000 shares $46.27 million -0.2%19.1%21 $8.19
4/30/20225,660,000 shares $61.69 million -1.9%19.1%20.4 $10.90
4/15/20225,770,000 shares $78.88 million -3.4%19.5%18.9 $13.67
3/31/20225,970,000 shares $83.70 million +10.8%N/A18.9 $14.02
3/15/20225,390,000 shares $75.24 million +8.0%18.3%17.1 $13.96
2/28/20224,990,000 shares $71.56 million +10.9%16.9%21.1 $14.34
2/15/20224,500,000 shares $65.16 million +32.0%15.3%20.1 $14.48
1/31/20223,410,000 shares $43.17 million -3.1%11.6%17 $12.66
1/15/20223,520,000 shares $52.80 million +5.4%N/A21 $15.00
12/31/20213,340,000 shares $68.20 million +3.4%11.3%22.7 $20.42
12/15/20213,230,000 shares $59.79 million +17.0%11.0%23.4 $18.51
11/30/20212,760,000 shares $53.52 million +9.1%9.4%15.8 $19.39
11/15/20212,530,000 shares $58.19 million -0.4%8.6%13.7 $23.00
10/29/20212,540,000 shares $59.56 million +5.8%9.3%12.8 $23.45
10/15/20212,400,000 shares $50.88 million -5.1%8.8%11.5 $21.20
9/30/20212,530,000 shares $56.37 million +30.4%9.3%11.2 $22.28
9/15/20211,940,000 shares $62.82 million +12.8%7.1%6.1 $32.38
8/31/20211,720,000 shares $61.39 million +44.5%6.5%5.8 $35.69
8/13/20211,190,000 shares $40.25 million No Change5.9%3.8 $33.82

GLUE Short Interest - Frequently Asked Questions

What is Monte Rosa Therapeutics' current short interest?

Short interest is the volume of Monte Rosa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 15,837,633 shares of GLUE short. 21.26% of Monte Rosa Therapeutics' shares are currently sold short. Learn More on Monte Rosa Therapeutics' current short interest.

What is a good short interest ratio for Monte Rosa Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLUE shares currently have a short interest ratio of 16.0. Learn More on Monte Rosa Therapeutics's short interest ratio.

Which institutional investors are shorting Monte Rosa Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Monte Rosa Therapeutics: Jane Street Group LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Monte Rosa Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.26% of Monte Rosa Therapeutics' floating shares are currently sold short.

Is Monte Rosa Therapeutics' short interest increasing or decreasing?

Monte Rosa Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 15,837,633 shares, an increase of 18.2% from the previous total of 13,398,925 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Monte Rosa Therapeutics' short interest compare to its competitors?

21.26% of Monte Rosa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Monte Rosa Therapeutics: Terns Pharmaceuticals, Inc. (10.72%), Centessa Pharmaceuticals PLC Sponsored ADR (2.42%), Apogee Therapeutics Inc. (24.06%), TG Therapeutics, Inc. (20.13%), Cogent Biosciences, Inc. (8.00%), Immunovant, Inc. (9.76%), CG Oncology, Inc. (12.19%), Rhythm Pharmaceuticals, Inc. (12.21%), PTC Therapeutics, Inc. (10.91%), Mirum Pharmaceuticals, Inc. (15.89%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Monte Rosa Therapeutics stock?

Short selling GLUE is an investing strategy that aims to generate trading profit from Monte Rosa Therapeutics as its price is falling. GLUE shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Monte Rosa Therapeutics?

A short squeeze for Monte Rosa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLUE, which in turn drives the price of the stock up even further.

How often is Monte Rosa Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLUE, twice per month. The most recent reporting period available is April, 15 2026.

What do GLUE's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like GLUE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:GLUE) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel